Bair MJ, et al. “Depression and Pain Comorbidity: A Literature Review,” Archives of Internal Medicine (Nov. 10, 2003): Vol. 163, No. 20, pp. 2433–45. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14609780

Bloom F. et al., eds. The Dana Guide to Brain Health (The Dana Press/The Free Press, 2003).

Busch AJ, et al. “Exercise for Treating Fibromyalgia Syndrome,” Cochrane Database of Systematic Reviews (Oct. 17, 2007): Doc. No. CD003786. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17943797

Gonsalkorale WM, et al. “Long Term Benefits of Hypnotherapy for Irritable Bowel Syndrome,” Gut (Nov. 2003): Vol. 52, No. 11, pp. 1623–29. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14570733

Kroenke K, et al. “Optimized Antidepressant Therapy and Pain Self-Management in Primary Care Patients with Depression and Musculoskeletal Pain: A Randomized Controlled Trial,” Journal of the American Medical Association (May 27, 2009): Vol. 301, No. 20, pp. 2099–110. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19470987

Kudoh A, et al. “Effect of Carbamazepine on Pain Scores of Unipolar Depressed Patients with Chronic Pain: A Trial of Off-On-Off-On Design,” Clinical Journal of Pain (March 1998): Vol. 14, No. 1, pp. 61–65. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9535315

Landefeld CS, et al. “The Neurontin Legacy – Marketing Through Misinformation and Manipulation,” New England Journal of Medicine (Jan. 8, 2009): Vol. 360, No. 2, pp. 103–06.

Lauria-Horner BA, et al. “Pregabalin: A New Anxiolytic,” Expert Opinion on Investigational Drugs (April 2003): Vol. 12, No. 4, pp. 663–72. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12665421

Nemeroff CB. “The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders,” Psychopharmacology Bulletin (2003): Vol. 37, No. 4, pp. 133–46. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15131523

Nicolson SE, et al. “Comorbid Pain, Depression, and Anxiety: Multifaceted Pathology Allows for Multifaceted Treatment,” Harvard Review of Psychiatry (Nov./Dec. 2009): Vol. 17, No. 6, pp. 407–20. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19968455

Pohl RB, et al. “Efficacy of Pregabalin in the Treatment of Generalized Anxiety Disorder: Double-Blind, Placebo-Controlled Comparison of BID versus TID Dosing,” Journal of Clinical Psychopharmacology (April 2005): Vol. 25, No. 2, pp. 151–58. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15738746

Rickels K, et al. “Pregabalin for Treatment of Generalized Anxiety Disorder: A 4-Week, Multicenter, Double-Blind, Placebo-Controlled Trial of Pregabalin and Alprazolam,” Archives of General Psychiatry (Sept. 2005): Vol. 62, No. 9, pp. 1022–30. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16143734

Spiller R, et al. “Guidelines on the Irritable Bowel Syndrome: Mechanisms and Practical Management,” Gut (Dec. 2007): Vol. 56, No. 12, pp. 1770–98. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17488783

Vedula SS, et al. “Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use,” New England Journal of Medicine (Nov. 12, 2009): Vol. 361, No. 20, pp. 1963–71.

Vranceanu AM, et al. “Psychosocial Aspects of Disabling Musculoskeletal Pain,” Journal of Bone and Joint Surgery (Aug. 2009): Vol. 91, No. 8, pp. 2014–18. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19651964

Wang C. “Tai Chi Improves Pain and Functional Status in Adults with Rheumatoid Arthritis: Results of a Pilot Single-Blinded Randomized Controlled Trial,” Medicine and Sport Science (2008): Vol. 52, pp. 218–29. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18487901